Search
Search Results
##search.searchResults.foundPlural##
-
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5544PDF: 1423HTML: 2884Cover letter: 250 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2175PDF: 1121HTML: 15745COVER LETTER: 246 -
CLINICAL AND LABORATORY FEATURES OF SICKLE CELL DISEASE S/D PUNJAB: IMPACT OF HBF AND HYDROXYUREA SCD S/D Punjab
1448PDF: 1227HTML: 169 -
Monocyte HLA-Dr Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia Monocyte HLA-DR expression in SCA patients
866PDF: 613HTML: 296 -
How I treat acute and persistent sickle cell pain
2139PDF: 1197HTML: 801 -
The INFLUENCE OF NUTRITION ON DISEASE SEVERITY AND HEALTH-RELATED QUALITY OF LIFE IN ADULTS WITH SICKLE CELL DISEASE A Prospective Longitudinal Study
2654PDF: 1025HTML: 389 -
Respiratory function in pediatric African SCA patients underwent bone marrow transplantation
2240PDF: 840HTML: 1095Spirometry in SCA patients before transplant: 258Spirometry in SCA patients post transplant: 227 -
Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era
1383PDF: 1027HTML: 112 -
Safety warning for ChAdOx1 nCov-19 vaccine in patients with sickle cell disease Astra Zeneca vaccine in Sickle cell disease (SCD)
2314PDF: 575HTML: 190 -
HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SEVERE PEDIATRIC SICKLE CELL DISEASE: OUTCOME AND LONG-TERM COMPLICATIONS, SAUDI EXPERIENCE AT KING FAISAL SPECIALIST HOSPITAL, RIYADH, SAUDI ARABIA HCT in in Severe Pediatric Sickle Cell Disease
1439PDF: 1035HTML: 518 -
-
HOMOZYGOUS DELETION ALFA-THALASSEMIA AND HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN, TWO GENETIC FACTORS PREDICTIVE THE REDUCTION OF MORBIDITY AND MORTALITY DURING PREGNANCY IN SICKLE CELL PATIENTS . A REPORT FROM DEMOCRATIC REPUBLIC OF CONGO ALPHA THALASSEMIA AND HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN REDUCE MORBIDITY DURING PREGNANCY IN SICKLE CELL PATIENTS
10756PDF: 1056HTML: 317 -
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
7184PDF: 3814HTML: 848 -
The COVID-19 in Omani children with chronic Hemato-oncology diseases COVID-19 in Omani children with chronic Hemato-oncology diseases
997PDF: 760HTML: 377 -
COMPARATIVE ANALYSIS OF CLINICAL AND LABORATORY DATA IN CHILDREN WITH MULTISYSTEM INFLAMMATORY SYNDROME ASSOCIATED WITH SARS-COV-2 IN THE REPUBLIC OF KAZAKHSTAN MULTISYSTEM INFLAMMATORY SYNDROME ASSOCIATED WITH SARS-COV-2
1209PDF: 637HTML: 391 -
CURRENT ISSUES AND OPTIONS FOR HORMONAL CONTRACEPTION IN ADOLESCENTS AND YOUNG ADULT WOMEN WITH SICKLE CELL DISEASE: AN UPDATE FOR HEALTH CARE PROFESSIONALS Hormonal Contraception in Adolescents and Young Adult Women With Sickle Cell Disease
2352PDF: 1522HTML: 1000
1 - 30 of 30 items







